Deutsche Bank’s Oncolytics Biotech ONCY Stock Holding History

Deutsche Bank’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,600	Closed	-$29K	–	4726
2021 Q1	$29K	Buy	+7,600	New	+$22.7K	﹤0.01%	4344
2020 Q1	–	Sell	-503	Closed	-$2K	–	4675
2019 Q4	$2K	Sell	503 -12,777	-96%	-$14.4K	﹤0.01%	4838
2019 Q3	$7K	Buy	13,280 +8,679	+189%	+$8.84K	﹤0.01%	4593
2019 Q2	$7K	Sell	4,601 -3,749	-45%	-$6.8K	﹤0.01%	5046
2019 Q1	$15K	Buy	8,350 +7,050	+542%	+$14.3K	﹤0.01%	4846
2018 Q4	$2K	Sell	1,300 -14,700	-92%	-$39.8K	﹤0.01%	5066
2018 Q3	$62K	Buy	16,000 +13,300	+493%	+$61.8K	﹤0.01%	4647
2018 Q2	$15K	Buy	+2,700	New	+$16.6K	﹤0.01%	5076

Other funds holding ONCY

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

ARC

Advisor Resource Council Dallas, Texas $355M AUM 30.05% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Deutsche Bank's ONCY Position: Q2 2021 in Review

Deutsche Bank sold out of Oncolytics Biotech (ONCY) in Q2 2021, closing a stake of 7,600 shares — an estimated $29K sold.

Deutsche Bank first reported a position in ONCY in Q2 2018 and held it in 8 quarters. The position peaked at $62K in Q3 2018. 44 funds tracked by Wall St. Rank hold ONCY as of Q2 2021.

Deutsche Bank reported no remaining Oncolytics Biotech position as of Q2 2021 after selling out during the quarter.
Deutsche Bank sold 7,600 Oncolytics Biotech shares in Q2 2021, an estimated $29K.
Deutsche Bank first reported a position in Oncolytics Biotech in Q2 2018 and held it in 8 quarters.
Deutsche Bank's Oncolytics Biotech position peaked at $62K in Q3 2018.
44 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2021.

Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.